Abstract. Besides initiating and propagating action potentials in established neuronal circuits, voltage-dependent sodium channels sculpt and bolster the functional neuronal network from early in embryonic development through adulthood (e.g., differentiation of oligodendrocyte precursor cells into oligodendrocytes, myelinating axon; competition between neighboring equipotential neurites for development into a single axon; enhancing and opposing functional interactions with attractive and repulsive molecules for axon pathfinding; extending and retracting terminal arborization of axon for correct synapse formation; experience-driven cognition; neuronal survival; and remyelination of demyelinated axons). Surprisingly, different patterns of action potentials direct homeostasis-based epigenetic selection for neurotransmitter phenotype, thus excitability by sodium channels specifying expression of inhibitory neurotransmitters. Mechanisms for these pleiotropic effects of sodium channels include reciprocal interactions between neurons and glia via neurotransmitters, growth factors, and cytokines at synapses and axons. Sodium channelopathies causing pain (e.g., allodynia) and neurodegeneration (e.g., multiple sclerosis) derive from 1) electrophysiological disturbances by insults (e.g., ischemia / hypoxia, toxins, and antibodies); 2) loss-of-physiological function or gain-of-pathological function of mutant sodium channel proteins; 3) spatiotemporal inappropriate expression of normal sodium channel proteins; or 4) de-repressed expression of otherwise silent sodium channel genes. Na v 1.7 proved to account for pain in human erythermalgia and inflammation, being the convincing molecular target of pain treatment.
Introduction
Historical milestones in the research of voltagedependent sodium channels have been engraved by the analysis of Na + currents of squid giant axon by Hodgkin and Huxley in 1949 (1), the purification of rat brain sodium channel protein by Hartshorne and Catterall in 1981 (2) , and the cloning of Electrophorus electric organ cDNA by Numa et al. in 1984 (3) . Between 1959 and 1982, Hubel and Wiesel performed pioneering studies showing that deprivation of visual experience impaired development of the visual system (4) .
From the beginning of the 1990s, several lines of accumulated experimental evidence indicated that both spontaneous and experience-driven electrical activities are essential for engraving and bolstering the structural basis for the functional neuronal network from early in embryonic development through adulthood (4 -7) through the following actions: [a] differentiation of oligodendrocyte precursor cells into oligodendrocytes that myelinate axon (8 -14) ; [b] stabilization of axon structure by heteroprotein assembly (15) ; [c] competition between neighboring equipotential neurites for selective development into a single axon; [d] axon growth cone pathfinding by enhancing and opposing crosstalk with attractive and repulsive molecular cues;
[e] extending and retracting arborization of terminal axon, ultimately navigating to correct synapse formation (4, 5, 16 -28) ; and [f] experience-induced cognitions (6) . In addition, sodium channels contribute to neuronal survival (29) , remyelination of demyelinated axons (13, 30 -35) , epigenetic selection of particular neurotransmitter phenotype out of the multiple repertories of neurotransmitters (36) , and auto-modulation of sodium channel expression per se (37) .
Sodium channels consist of the principal α-subunit, without or with a noncovalently-attached β 1 -or β 3 -subunit, and a disulfide-linked β 2 -or β 4 -subunit, depending on the tissues and species (38 -40) . The α-subunit is composed of four homologous domains (I -IV), each containing six transmembrane segments (S1 -S6), and the ion-pore and the five distinct toxin binding sites that form site 1 for tetrodotoxin ([TTX)/ saxitoxin (STX), site 2 for veratridine, and site 3 for α-scorpion toxin] (38, 41, 42) . The nine isoforms of α-subunits (Na v 1.1 -Na v 1.9 in Table 1 ) arise from nine different genes (SCN1A-SCN5A and SCN8A-SCN11A). The β-subunits are type 1 transmembrane proteins harboring a single membrane-spanning region. Distinctly, the extracellular domain of β-subunit contains a single immunoglobulin V-set fold structure, that enables the β-subunit to interact with cell adhesion molecules (e.g., neurofascin), extracellular matrix proteins (e.g., tenascin), and intracellular scaffold proteins (e.g., ankyrin) (39, 40) . In this context, it should be noted that expressions studies indicate that β-subunits regulate gating kinetics and cell surface density of sodium channels (39, 40, 43) .
Density and activity of sodium channels are regulated via not-fully defined mechanisms during cell development and differentiation; interestingly, different patterns of action potentials convey distinct information, which is decoded via unidentified mechanisms to regulate genotypic and phenotypic events (6, 7, 11, 17) . Unfortunately, there exist multiple layers of sodium channel abnormalities: [a] altered functions of normal sodium channel proteins by noxious insults (e.g., ischemia / hypoxia, toxins, or antibodies) or structural damages (e.g., demyelination, desmyelination, or remyelination failure) (13, 30 -35, 44 -51) ; [b] expression of mutant sodium channel proteins (52 -59) ; and [c] aberrant expression levels of normal sodium channel proteins or otherwise silent normal sodium channel genes (37, 42) . These sodium channelopathies cause seizure, skeletal muscle paralysis, fatal cardiac arrhythmia, ataxia, inflammatory pain (37, 38, 52, 59 -63) , and painful diabetic neuropathy (64, 65) , as well as neurodegenerative multiple sclerosis (30 -35, 37, 44, 48 -51) (Table 1) .
In 2004, it was found that a gain-of-function mutation of Na v 1.7 was responsible for human disease erythermalgia (Table 1) , a burning pain syndrome in the extremities first described in 1878 (52) . Importantly, Na v 1.7 also plays a role in eliciting intolerable pain in inflammation (62, 63) and diabetic neuropathy (64, 65) , Na v 1.7 being the first convincing molecular target of therapeutic drugs against pain. In this context, Table 2 may be informative; it summarizes our previous studies showing that density and activity of cell surface Na v 1.7 were up-or down-regulated by various therapeutic drugs and cellular signals in cultured bovine adrenal chromaffin cells (which are embryologically derived from the neural crest and are homologous to sympathetic ganglion neurons). For more detailed information, the readers are advised to refer to our review article (42) and original reports (66 -76) .
Despite these multiple layers of research advances, relatively less attention has been paid to sodium channels, so I would like to introduce the readers to the increasing number of previously unrecognized roles of these channels in [a] axon development and neuronal circuit formation ( Fig. 1 and Table 3 ), as well as [b] pain, neuronal degeneration, and regeneration (Table 4) . There are some nice review articles that provide more extensive descriptions about sodium channels and their structures and functions (38, 39, 41) and their roles in pain (37, 52, 59 -61) and multiple sclerosis (44) .
Requirement of sodium channels for sculpting and bolstering functional neuronal network
Axon navigation and synapse formation: promotion by neuronal electrical activity The pioneering studies of Hubel and Wiesel between 1959 and 1982 paved the way for the first evidence that normal visual experience is necessary in the early stage of life for the proper development of the visual system (4, 5) . Visual impairments remained permanently in children born with cataracts even if they were given surgery for this condition at 4 -6 years of age (4) . Monocular eye closure in cats led to less organized neuronal connections, with dramatic anatomical and physiological changes in the striate cortex (4). In addition to the experience-induced electrical activity, even the spontaneous electrical activity of neurons promoted visual connections (17) . In the very early developmental stage of the visual system when the axons traverse the thalamocortical pathway, blockade of action potentials by TTX in the thalamic neurons impaired normal terminal arborization of axons to the visual cortex, causing mis-projection of thalamic neurons to other unrelated cortical areas (18 -22) .
Much remains, however, unknown whether surviving neurons can extend axons constitutively by default in the absence of any extracellular signal or require the extracellular signals for axon extension. In 2002, Goldberg et al. (23) investigated these possibilities. In cultured rat retinal ganglion neurons, overexpression of Bcl-2 was sufficient to maintain the survival of neurons in the absence of any trophic molecular cue; however, Bcl-2-expressing neurons did not extend axons, unless being stimulated by a single peptide trophic factor [e.g., brain-derived neurotrophic factor (BDNF), insulin, gliaderived neurotrophic factor (GDNF), or nerve growth factor (NGF)] in the culture medium. Therefore, cell survival per se was not sufficient for axon growth; the trophic factor-induced axon growth was, however, a remarkably slow process, but it was profoundly accelerated by physiological levels of spontaneous electrical activity of neurons (23) .
In the neocortex, horizontal axons run in layer 2 / 3 for a long distance and form axon branches to make synaptic contacts in the same layer; the organization of these connections was affected by visual experience deprivation (18) and by blockade of action potentials (20) . By using an organotypic slice culture of horizontal axons of rat visual cortex (a culture system capable of perserving the fine structures such as axons and dendrites), Uesaka et al. (16, 17) showed that TTX suppressed both neuronal electrical activity and branching of the terminal arborization of axons. Axon branching is a dynamic extending and retracting process important for establishing the final pattern of connections between a neuron and its target cells; it was previously shown that N-methyl-D-aspartic acid (NMDA) type glutamate receptors played a role in axon branching. Uesaka et al. (16, 17) , however, observed that 6,7-dinitroquinoxaline-2,3-dion (DNQX), an antagonist of non-NMDA type glutamate receptors [but not 2-amino-5-phosphonovaleric acid (APV), an antagonist of NMDA type glutamate receptors] blocked axonal branching; unlike TTX, however, DNQX failed to reduce neuronal electrical activity per se (16, 17) . The authors concluded that neuronal electrical activity promoted developmental branching of cortical neurons by activating non-NMDA receptors, which may locate at postsynaptic neurons and may increase the secretion of an as yet unidentified neurotransmitter(s) (e.g., BDNF) from the postsynaptic neurons, accelerating the retrograde synaptic transmission directed to presynaptic nerve terminals. Structural integrity of axon initial segment by sodium channel: heteroprotein assembly Neurons usually receive thousands of synaptic inputs from dendrites; thus, fundamental to an understanding of how neurons integrate synaptic inputs is to identify the site where neurons convert the input information into output signals, action potentials. The exact initiation site of action potentials, however, has long been the subject of much debate. In 2006, by using layer V neurons of the pyramidal tract, Palmer and Stuart (77) documented that action potentials were generated in the distal region of the axon initial segment (approx. 35-µm away from the axon hillock), but not in the first node of Ranvier (approx. 90-µm away from the axon hillock).
The initial segment of an axon, like nodes of Ranvier, is characterized by a high-density of sodium channels Fig. 1 . Development of neuron. In the adult neuron, multiple dendrites receive signals, whereas a single axon sends signals (i.e., neuronal polarity). In the embryonic neuron, a fast growing neurite develops into an axon, whereas the others become dendrites. All processes of neurons shown at stages 1 through 4 are regulated by electrical activity. During action potentials, ATP released from axons promotes differentiation of oligodendrocyte precursor cells into oligodendrocytes via P1 receptors, and these oligodendrocytes myelinate axons in the central nervous system; in contrast, ATP from axons inhibits Schwann cellinduced axon myelination via P2Y receptors in the peripheral nervous system (7 -14) . In addition, ATP from axons increases secretion of leukemia inhibitory factor from astrocytes, favoring axon myelination by oligodendrocytes (14) . Numbers in parentheses show references (see Table 3 ). Table 3 . Axon myelination in central versus peripheral nervous system: distinct effects of reciprocal communications between neurons and glial cells (see Fig. 1 )
Central nervous system
Peripheral nervous system A. Neurons and oligodendrocytes B. Neurons and astrocytes-oligodendrocytes C. Neurons and Schwann cells 1. ATP release from axon firing action potentials (7, 12, 14) 2. Adenosine P1 receptors on oligodendrocyte precursor cells (7, 12 -14) 2. New role of purinergic P2 receptors on astrocytes: secretion of leukemia inhibitory factor (7, 14) 2. Purinergic P2Y receptors on Schwann cells: inhibition of both Schwann cell differentiation and axon myelination (7, 12, 13) 3. Differentiation of oligodendrocyte precursor cells into oligodendrocytes: axon myelination (7 -13) 3. New role of leukemia inhibitory factor at oligodendrocytes: enhancement of axon myelination (7, 14) Numbers in parentheses show references. In cultured embryonic rat motor neurons, knockdown of multiple sodium channel α-subunit isoforms caused by transfection of small hairpin RNAs decreased expression of functional sodium channels at the axon initial segment, thereby interfering with heteroprotein complex formation between ankyrin G , neuronal cell adhesion molecule, and neurofascin at the axon initial segment. Previous studies have shown that neuronal cell adhesion molecule and L1 cell adhesion molecule regulated axon myelination and remyelination, which were summarized in a review article (13) .
Axon myelination by reciprocal communications between neurons and glial cells: central versus peripheral nervous system By using mouse in vivo developing optic nerve and cultured cerebral neurons, Demerens et al. (10) examined whether electrical activity of axons could promote axon myelination; TTX inhibited myelination, whereas opening of sodium channels by α-scorpion toxin promoted myelination. In cultured mouse dorsal root ganglion (DRG) neurons, Stevens et al. (11) showed that specific frequencies of action potential firing, rather than the overall level of impulse activity, was required for axon myelination.
However, little is known about the mechanisms governing the onset of axon myelination by electrical activity (13, 32) . Electrical activity-dependent communication between axons and myelinating glial cells can occur in the vicinity of axolemma away from the synapse (7). As shown in Table 3 , Fields and his colleagues (7, 12, 14) found that ATP was released from axons that evoked trains of action potential firings. Then, ATP acted at adenosine P1 receptors on oligodendrocyte precursor cells, inhibited their proliferation, but promoted their differentiation into the oligodendrocytes, promoting axon myelination in the central nervous system. In 2006, Ishibashi et al. (14) found another mechanism for axon myelination. In cultured mouse DRG neurons, ATP released from axons bound to purinergic P2 receptors on astrocytes (but not adenosine P1 receptors on oligodendrocytes) and caused the release of leukemia inhibitory factor, which in turn promoted axon myelination by oligodendrocytes. Thus, a novel mechanism was unveiled for the action potential-induced axon myelination, involving cooperative interactions between astrocytes and oligodendrocytes and between purinergic and cytokine signalings.
In striking contrast to the central nervous system, electrical activity of axons retarded axon myelination in the peripheral nervous system (7, 12) . ATP released from axons activated purinergic P2Y receptors on Schwann cells and inhibited proliferation and differentiation of Schwann cells, thus blocking Schwann cell- induced axon myelination in the peripheral nervous system (7, 12) .
Involvement of axon myelination in experience-driven cognition Myelination continues through childhood into early adulthood, whereas its physiological significance remains unclear (6, 7) . In animals, rearing environments with enriched sensory and social stimulation increased axon myelination; also, vice versa (6, 7). In adult human brains, piano practice increased axon myelination (6); [a] there was a positive correlation between piano practice hours and axon myelination, when compared between professional concert pianists and age-matched controls or compared within the group of professional pianists; and [b] piano practice at different ages (e.g., childhood, adolescence, and adulthood) promoted the axon myelination at different white matter tracts.
In vitro development into axon: advantage to depolarized over nondepolarized neurites
A mature neuron typically has a single axon and multiple dendrites (Fig. 1 ). Dendrites usually receive signals, whereas the axon usually sends signals; the differentiation into axon and dendrites from neurites, referred to as neuronal polarity, is indispensable to neuronal transmission, although the underlying molecular mechanisms remain largely unknown (67, 78 ). An embryonic neuron extends multiple equipotential neurites; the fastest growing neurite is destined to develop into an axon, whereas the others eventually become dendrites.
In 2005, Singh and Miller (24) examined whether electrical activity of neurons could influence the development of neurites into axon. They used a compartmented three chamber culture system of sympathetic neurons prepared from newborn rat superior cervical ganglion. In this system, neuronal cell bodies were placed in the center compartment. Neurites were placed in the sealed compartments at both sides, then transected, and subjected to independent experimental manipulations in each compartment; the growth rate into axon was assessed by measuring the de novo growth of the longest neurite. In the presence of NGF, local depolarization of neurite caused by high K + or patterned electrical stimulation promoted its growth into axon, compared to NGF alone. In addition, a competition experimental paradigm showed that local depolarization conferred a competitive growth advantage on the depolarized neurite, which was associated with growth disadvantage on the nondepolarized neurite derived from the same neuronal cell body. The competitive growth advantage was dependent on depolarizationinduced Ca 2+ influx via L-type calcium channels. An increase of cytoplasmic Ca 2+ concentration activated Ca 2+ / calmodulin-dependent protein kinase II and the extracellular signal-regulated kinase pathway, which converged with NGF-induced activation of the extracellular signal-regulated kinase pathway. In contrast, the competitive growth disadvantage of nondepolarized neurite was partly mediated via a paracrine mechanism. BDNF was secreted from depolarized sympathetic neurons and bound to p75 neurotrophin receptors located at nondepolarized neurite, producing the growth disadvantage; these disadvantage inducing mechanisms were inferred from the preventing effect of a functionblocking antibody for BDNF or p75 neurotrophin receptors on growth disadvantage.
In vivo competitive growth between neighboring axons: regulation by sodium channels and potassium channels
In the peripheral junction between motor neurons and skeletal muscle of neonatal animals, each single skeletal muscle cell is innervated by several axons that are collaterals of multiple motor neurons (polyneuronal innervation), whereas each adult skeletal muscle cell makes contact with one single axon (mononeuronal innervation) (79) . Thus, current dogma holds that electrical activity of motor neurons ultimately shapes up terminal multiple axons into a single axon by eliminating the existing axons. Elimination-based elaboration of axon terminal arborization has been shown to operate in the brain visual system (17, 18) .
In 2005, Hua et al. (25) discovered another mechanism by which neuronal electrical activity could positively shape up axon terminal arborization by promoting formation of a new branch, instead of eliminating old existing branches; sodium channel activity increased, whereas potassium channel activity decreased, arbor length and branch number. In zebrafish larvae embryos, individual retinal ganglion neurons were transfected without or with human inward rectifier potassium channel Kir2.1. The in vivo transfected neurons became inactive at 5 days after fertilization, because of the hyperpolarization caused by Kir2.1 overexpression. Their axons showed the retardation of arbor growth and the less elaborate extension of terminal arbors, compared with the control active Kir2.1-nontransfected axons or axons transfected with the non-conducting mutant Kir2.1.
Subsequently, all retinal ganglion neurons were silenced by intraocular injection of TTX (25) . TTX treatment did not affect the morphology of axons and restored the ability of Kir2.1-expressing axons to grow the terminal arbors to the same extent as did the control active Kir2.1-nontransfected axons. Thus, rela-tive potencies of electrical activity between neighboring axons determined their capacities to extend new branches; retardation of terminal arbor growth in inactive axons may be due to the loss of competition with the neighboring active axons, which fully developed their terminal arbors.
Hua et al. (25) found that the inhibitory effect of Kir2.1 on axon terminal growth was reproduced in zebrafishes transfected with the dominant-negative SNARE protein that is known to suppress the recycling of synaptic vesicles, thus blocking exocytic secretion of neurotransmitters. The authors speculated that the neurotransmitter(s) secreted from active axons may act at nearby presynaptic axon arbors in a paracrine manner or may interact with postsynaptic tectal cells in the retinotectal projection of visual system or glial cells, exerting feedback-regulation onto retinal ganglion neurons via retrograde signal candidates (e.g., neurotrophins, nitric oxide, and arachidonic acid).
Molecular cue-induced attractive and repulsive turning of axon growth cone: enhancing and opposing modifications by electrical activity
In cultured embryonic Xenopus spinal neurons, Ming et al. (26) observed that a concentration gradient of extracellular netrin-1 normally induced repulsive turning of extending growth cones in young cultures (<10 h in culture), while causing attractive turning of extending growth cones in older cultures (>16 h in culture); surprisingly, pre-exposure of the young cultures to brief periods of electrical stimulation converted netrin-1-induced repulsive turning into attractive turning, while enhancing netrin-1-induced attractive turning in older cultures. In growth cones of older cultures, repulsion caused by myelin-associated glycoprotein or myelin membrane fragments was converted into attraction by electrical stimulation. These effects of electrical stimulation were dependent on the stimulation pattern, persisted for a period less than 30 min, and required cytoplasmic Ca 2+ concentration increase followed by activation of Ca 2+ -dependent adenylate cyclase. In contrast, the same electrical stimulation converted semaphorin 3A-induced repulsion into collapse of growth cones in a Ca 2+ -dependent manner. It is known that the existence of direct-current electrical fields is widespread in the extracellular space of developing, injured, and regenerating tissues (80) . In the native biological milieu, the electrical fields cooperate with chemotropic molecular guidance cues, thereby elaborating development (e.g., correct pathfinding of axon growth cone) and regeneration of the nervous system, as introduced in a review article (80) .
Pharmacological intervention of electrical activity: axon pathfinding error in early stage of synapse formation It has been shown that during the early developmental phase of embryonic spinal cord, γ-aminobutyric acid (GABA) generates excitatory (but not inhibitory) currents, which is essential to the electrical activity of motor neurons. To investigate the significance of early motor neuron activity, Hanson and Landmesser (27) used picrotoxin, an antagonist of the GABA A receptor, to reduce burst activity during this early developmental period. They observed that chronic in ovo application of picrotoxin culminated in the abnormal localizations of motor neurons that innervate chick ventral and dorsal hindlimb muscles; the discordant locations between cell bodies and axon trajectories of motor neurons were likely to be due to the errors of axon growth cone pathfinding caused by picrotoxin.
In picrotoxin-treated embryos, the level of polysialic acid conjugated-neuronal cell adhesion molecule was markedly decreased on the surface of motor neuron axons in the plexus region (27) , consistent with previous findings that enzymatic removal of polysialic acid from neuronal cell adhesion molecule resulted in the axon pathfinding errors of motor neurons in the plexus region (81) .
Axon growth and axon trajectory formation are also regulated by contactin, a cell adhesion / recognition molecule of the immunoglobulin superfamily. In rat hypothalamic organotypic slice cultures, Pierre et al. (28) documented that cell surface targeting transport of contactin was accelerated by neuronal activity stimulation (due to high K + depolarization or GABA A -receptor blockade by bicuculline) and inhibited by neuronal activity depression (due to Ca 2+ -channel blockade with Mn 2+ , TTX, or glutamate antagonists). Thus, neuronal electrical activity promoted cell surface expression of contactin, regulating axon growth and axon trajectory formation.
Prevention of dopaminergic neuron apoptosis by sodium channel activators veratridine and α-scorpion toxin
In the mesencephalon, degenerative loss of dopaminergic neurons in the nigrostriatal pathway accounts for the disabling motor abnormalities in Parkinson's disease. Immunohistochemical study with anti-tyrosine hydroxylase antibody by Salthun-Lassalle et al. (29) showed that cultured dopaminergic neurons of embryonic rats underwent spontaneous apoptotic cell death, with condensed and fragmented chromatin. When the sodium channel agonist veratridine was applied chronically to the cultures, the apoptosis of tyrosine hydroxylase-positive neurons was prevented by approx. 74% in a concentration-and time-dependent manner; neuroprotection by veratridine was specific to dopaminergic neurons (but not to GABAergic neurons), and shortlived after veratridine withdrawal. α-Scorpion toxin mimicked the survival promoting effect of veratridine. These effects of veratridine and α-scorpion toxin were abolished when TTX was added to the cultures.
Manipulation of neurotransmitter phenotype in embryo: electrical activity-dependent homeostatic mechanism
The type of neurotransmitter that a specific neuron synthesizes and through which it communicates with other neurons has been thought to be encoded in the genetic program and is invariable throughout the lifetime of an organism. Virtually nothing is known, however, about how specific neurons can express their own neurotransmitters (i.e., neurotransmitter phenotype). In 2004, surprisingly, Borodinsky et al. (36) provided the first evidence that neuronal electrical activity could induce the epigenetic alterations of neurotransmitter phenotype. In developing spinal cord of Xenopus laevis embryos, enhancement of electrical activity by overexpression of Na v 1.2 decreased expression of acetylcholine and glutamate (excitatory neurotransmitters), while increasing expression of GABA and glycine (inhibitory neurotransmitters); the reverse occurred when the electrical activity was suppressed by overexpression of inward rectifier potassium channel Kir2.1.
A Ca 2+ -channel antagonist increased, whereas veratridine decreased expression of glutamate and acetylcholine; there was an inverse relationship between Ca 2+ spike activity and expression of excitatory neurotransmitters. In some neurons, decreased expressions of GABA and glycine were accompanied by increased expressions of glutamate and acetylcholine; thus, it was surprising that contemporary coexpression of inhibitory and excitatory neurotransmitters could occur in this experimental system. In addition, neurons harboring ectopic expression of glutamate and acetylcholine could secrete glutamate and acetylcholine, as evidenced by the generation of synaptic currents that were inhibited by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), an antagonist of non-NMDA type glutamate receptors, or d-tubocurarine, an antagonist of nicotinic acetylcholine receptors. There was a critical period at this early stage of development during which Ca 2+ spike activity could alter neurotransmitter phenotype.
Sodium channel remodeling in pain: inflammation, diabetic neuropathy, and erythermalgia
Neuronal injury: dysregulated expression of Na v 1.3, Na v 1.6, Na v 1.7, Na v 1.8, and Na v 1.9
Sodium channels contribute to the hyperexcitability of DRG neurons associated with pain. DRG neurons of rodents express TTX / STX-sensitive sodium channel α-subunits (Na v 1.7, Na v 1.1, Na v 1.6, Na v 1.2, and Na v 1.3) and TTX/ STX-resistant sodium channel α-subunits (Na v 1.8 and Na v 1.9) (Table 1) (37, 38, 60, 61, 82 ). As summarized in Table 4 , transection of peripheral (but not central) axons of spinal sensory neurons in rats turned off expression of normal active sodium channel genes, while turning on expression of otherwise silent sodium channel genes, the combined changes in repertories of sodium channel isoform expression causing hyperexcitability-associated chronic pain (37, 60, 61) . In peripherally axotomized spinal sensory neurons, expressions of Na v 1.8 and Na v 1.9 were down-regulated, whereas Na v 1.3 level was up-regulated. Because Na + currents via Na v 1.3 recover rapidly from inactivation, Na v 1.3 up-regulation may decrease the refractory period, causing high-frequency bursts of currents and hyperexcitability of neurons after nerve injury. Although the factors altering expression of sodium channel isoforms after nerve injury are not fully clear, impaired access to peripheral pools of neurotrophic factors (e.g., NGF and GDNF) may be involved in the changes in sodium channel expression. Delivery of NGF and GDNF to peripherally axotomized spinal sensory neurons upregulated Na v 1.8 and Na v 1.9 at the mRNA and protein levels, as well as Na + currents via Na v 1.8 and Na v 1.9; in contrast, NGF and GDNF down-regulated Na v 1.3 expression in spinal sensory neurons (37) .
In rat DRG neurons, Na v 1.6 and Na v 1.7 mRNA levels were decreased after the segmental spinal nerve ligation (83) . In DRG neurons from human patients with brachial plexus injury, Coward et al. documented that the neuronal injury caused down-regulation of Na v 1.8 and Na v 1.9 proteins (84). In human injured DRG, they also found that Na v 1.7 was down-regulated by central axotomy, while being up-regulated by peripheral axotomy; Na v 1.3 was detectable only in injured nerves (85) .
It is clear that pain invokes both a purely sensory component and an additional affective / behavioral component, the latter conveying the information to motivate behavior for reduction of pain (86, 87) . Braz et al. (86) documented that the parallel, presumably independent, pain pathways arise from peptidergic and nonpeptidergic subgroups of nociceptive neurons at spinal cord; more importantly, both pathways project via distinct routes to limbic regions of the brain, thus presumably coordinating appetitive, reproductive, and defensive behaviors. In knockout mice lacking the ATPgated cation channel P2X 3 in nonpeptidergic neurons, thermal avoidance behavior was unexpectedly enhanced when the animals were placed in a thermal gradient (87) . In these peptidergic and nonpeptidergic neuronal circuits, however, specific roles of multiple Na v isoforms still remain elusive.
Neuronal injury and allodynia: up-regulation of sodium channel β 2 -subunit
In rat models for neuronal injuries of various peripheral afferent neurons, Pertin et al. (43) demonstrated that sodium channel β 2 -subunit protein level was increased in cell bodies and peripheral axons of injured neurons and neighboring non-injured neurons, with no increase of sodium channel β 2 -subunit mRNA level. The authors speculated that neuronal injury-induced upregulation of β 2 -subunit protein may be attributed to the promotion of β 2 -subunit mRNA translation and/ or the retardation of proteolytic degradation of β 2 -subunit protein. Similar pattern of changes occurred in the spinal ligation model of neuropathic pain; dysregulated increased expression of the β 2 -subunit may be involved in the development of allodynia, as demonstrated by the lack of mechanical allodynia-like behavior in the β 2 -subunit null mutant mice. Because β-subunits regulated cell surface expression of sodium channels, and β 2 -subunit mediated cell-cell adhesion and migration (39, 88) , these correlative results suggested that neuronal injury-induced increase of β 2 -subunit level resulted in the aberrant up-regulation of cell surface expression of functional sodium channels, accounting for generation of allodynia.
Unlike a gene family of ion-pore forming α-subunits of voltage-dependent ion (Na + , Ca 2+ , and K + ) channels, sodium channel β-subunits are not structurally related to β-subunits of voltage-dependent calcium channels and voltage-dependent potassium channels. Previous expression studies have shown that sodium channel β-subunit accelerated gating kinetics and cell surface targeting of sodium channels; these observations may be compatible with the notion that sodium channel β-subunit can function as a cell adhesion molecule via its extracellular immunoglobulin V-set fold structure (39, 40, 43) . In 2005, Kim et al. (88) documented that the β 2 -subunit was a substrate for α-secretase and γ-secretase; after the extracellular domain of β 2 -subunit was shed by α-secretase, the remaining transmembrane segment of β 2 -subunit was cleaved by γ-secretase, culminating in cellcell adhesion and migration of β 2 -subunit-expressing cells. In addition, Wong et al. (89) documented that β 1 -, β 2 -, β 3 -, and β 4 -subunits were sequentially cleaved by β-secretase and γ-secretase; these secretases have received widespread attention because they catalyze sequential proteolysis of β-amyloid precursor protein, yielding amyloidogenic β-amyloid peptides responsible for Alzheimer's disease (67, 78) . However, the physiological significance of proteolytic cleavage of β 1 -, β 2 -, β 3 -, and β 4 -subunits remains elusive in any given tissue.
Mutant Na v 1.7: intolerable pain syndrome erythermalgia Erythermalgia is characterized by the intermittent burning pain in the hands and feet in response to warm stimuli or exercise (52) . It was originally termed erythromelgia (erythros = redness; melos = extremity; algos = pain) by the American neurologist Silas Weir Mitchell in 1878 (see ref. 52 for review). The symptoms can be alleviated by cooling of the limbs; the patients are compelled not to wear socks or closed shoes even in winter and to search for relief by immersion of feet in ice-cold water, precipitating gangrene. The natural history of 168 patients with erythermalgia between 1970 and 1994 was summarized by Davis et al. (53) . Both the primary inherited autosomal dominant form and secondary non-inherited form of erythermalgia have been described. The former inherited form spontaneously arises during early childhood and adolescence without underlying disorder (53) . The latter noninherited form is associated with myeloproliferative diseases (e.g., polycythemia vera) and drug treatment (e.g., Ca
2+
-channel antagonists). Occasionally, patients develop erythermalgia without obvious predisposing illness and familial inheritance.
Importantly, erythermalgia is the first human disease in which chronic neuropathic pain was convincingly documented to be attributed to the mutation of ion channels, namely Na v 1.7. Three discoveries could elucidate the molecular basis of erythermalgia (52) . Linkage analysis established that a primary erythermalgia susceptible gene was located on chromosome 2q31-32 (54, 56) . Two mutations within this locus for SCN9A, a gene coding for the human Na v 1.7, were found in patients with erythermalgia (52, 55) . The two mutant forms of Na v 1.7 (I848T and L855H) were expressed in human embryonic kidney 293 cells and analyzed by patch clamp study. Expression of I848T or L855H produced a hyperpolarizing shift in activation of the channel (thereby lowering the threshold for channel opening) and a slowing of channel inactivation (keeping the channels open for a longer period, when the stimulus is removed), as well as an enhancement of the current amplitude in response to slow, small subthreshold depolarizing stimuli (52, 56) . Mutation at F1449V of Na v 1.7 exhibited similar biophysical properties as I848T or L855H, but with no increase of the current amplitude to slow, small depolarizing stimuli (52, 57) . In addition, for sporadic or primary autosomal dominant erythermalgia, there may be a new mutation of Na v 1.7 or a mutation other than Na v 1.7 (52, 58) .
In DRG neurons, it has been shown that Na v 1.7 produced depolarization in the early phase of electrogenesis; such depolarization boosted small subthreshold input, thereby bringing DRG neurons to membrane potentials that activated Na v 1.8. Na v 1.8 has a relatively depolarized activation threshold, but is important for excitability, because Na v 1.8 carries most of the upstroke current of action potentials. DRG neurons were transfected with wild-type or mutant F1449V Na v 1.7; expression of the mutant Na v 1.7 produced a lower current threshold for generation of single action potentials, and a higher frequency firing at graded stimulation intensities, causing neuronal hyperexcitability, when compared to wild-type Na v 1.7 (52, 57) .
Treatment of erythermalgia has been empirical; it has included various drugs (e.g., nonsteroidal antiinflammatory drugs, vasodilators, and vasoconstrictors), sympathetic blockade, and sympathectomy, producing inconsistent or partial success at best (52) . Local anesthetics lidocaine and mexiletine have been reported to reduce pain in patients with primary erythermalgia (52) . It may be noted that pharmacological blockade of lumbar sympathetic ganglia or surgical thoracic sympathectomy dramatically relieved intolerable pain in human erythermalgia patients, with the improvement of microcirculation disturbances in the affected extremities (Discussion in ref. 90 ).
Bipartite roles of Na v 1.7 mutation: hyperexcitability in sensory ganglion and hypoexcitability in sympathetic ganglion Disease-producing mutations of ion channels are usually characterized as causing either hyperexcitability or hypoexcitability. Previous in situ hybridization studies showed that Na v 1.7 mRNA was confined to the neuronal cell population within the peripheral sensory ganglion (e.g., DRG) and sympathetic ganglion (e.g., superior cervical ganglion), with no detection in other tissues examined (e.g., brain) (91, 92). Rush et al. (93) investigated the effects of Na v 1.7 mutation (L858H) on electrical excitability of these afferent and efferent ganglion neurons. L858H mutation produced a depolarizing shift in resting membrane potential in both types of neurons. Surprisingly, L858H mutation rendered DRG neurons hyperexcitable, while causing superior cervical ganglion neurons hypoexcitable. These opposite functional effects of L858H were thought to be due to the selective existence of Na v 1.8 in DRG neurons, but not in superior cervical ganglion neurons. Na v 1.7 mutation in sympathetic ganglion, however, seems to be involved in causing sympathetic dysfunctions reported in erythermalgia (94, 95) .
Inflammatory and diabetic neuropathy pain: up-regulation of Na v 1.7
Global Na v 1.7 null mutant mice die shortly after birth. In knockout mice specifically lacking nociceptor Na v 1.7, acute inflammatory pain responses evoked by various stimuli (e.g., carrageenan, Freund's adjuvant, or formalin) were reduced or abolished (62) . In rats receiving carrageenan injection into the hind paw, the peripheral inflammation was associated with the up-regulation of Na v 1.7 level and TTX-sensitive Na + current amplitude in the DRG neurons (96) . In rat DRG neurons, herpes vector-mediated knockdown of Na v 1.7 prevented the development of hyperalgesia in response to Freund's adjuvant (63) . These results suggested that increased expression or activity of Na v 1.7 was involved in the development of inflammatory hyperalgesia; erythermalgia is a model disease that is useful for understanding of pathology and treatment of inflammatory hyperalgesia.
In rats subjected to hind paw injection of carrageenan or Freund's adjuvant, Na v 1.8 mRNA and protein levels were elevated in DRG neurons projecting to the inflamed limb; also, amplitude and density of TTXresistant sodium currents were increased in inflammation-linked DRG neurons (60) .
Streptozotocin-treated diabetic rats demonstrated allodynia (escape behavior from intolerable pain generated by otherwise innocuous mechanical pressure) and hyperalgesia to noxious thermal stimulus between 4 -8 weeks after onset of diabetes mellitus (64) . In DRG neurons of these diabetic rats, immunoblots and immunofluorescene staining showed significant increases in the expression of Na v 1.3 and Na v 1.7, with reduced expression of Na v 1.6 and Na v 1.8. In rats with streptozotocin-induced diabetes and tactile allodynia, there were up-regulations of Na v 1.3, Na v 1.6, and Na v 1.9, as well as down-regulation of Na v 1.8 at the mRNA and protein levels (65) .
Localization of Na v 1.7 at axon growth cone
In cultured rat DRG neurons, immunocytochemical study demonstrated that Na v 1.7 protein was localized predominantly in the axon growth cone, with lower levels of Na v 1.7 protein along the length of neurites and trans-Golgi network (92) . In differentiated PC12 cells by NGF treatment, Na v 1.7 protein level was highest at the axon growth cone, occasionally being detected at the cell periphery, particularly at sites of cell-cell contact (92) . In DRG neurons and differentiated PC12 cells, therefore, Na v 1.7 protein was targeted from the transGolgi network to the axon growth cone, a neuronal compartment thought to be multifunctional, culminating into correct synapse formation.
Sodium channel remodeling in neurodegeneration: demyelination and remyelination
Abnormal distribution of Na v 1.2 and Na v 1.6 in dysmyelinated axons and demyelinated axons
At the early developmental stage before axon myelination, Na v 1.2 is distributed diffusely along premyelinated axons, supporting action potentials (38, 44) . As myelination proceeds, Na v 1.2 is replaced by Na v 1.6, which clusters at the mature nodes of Ranvier in myelinated axons, but is spare in the paranodal and juxtaparanodal membranes under the myelin sheath.
In Shivever mutant mice, its gene mutation coding for the myelin basic protein led to severe dysmyelination of axons; in dysmyelinated axons of Shivever, Na v 1.2 continued to be expressed diffusely, whereas Na v 1.6 was not expressed (44, 97) (Table 4) .
In multiple sclerosis, loss of myelin sheath and loss of axon occur within the white matter of the brain and spinal cord (13, 32, 44) . In mice being rendered to experimental autoimmune encephalomyelitis, an animal model of human multiple sclerosis, Na v 1.2 and Na v 1.6 distributed diffusely along almost the entire length of demyelinated axons of the optic nerve, with the upregulation of Na v 1.2 mRNA level (44, 49 -51) . In contrast, Na v 1.1 and Na v 1.3 were not detectable in optic nerves of mouse multiple sclerosis model (44, 49) , although Na v 1.3 was up-regulated in DRG neurons by nerve injury (37, 59 -61, 85) .
Ectopic expression of sensory Na v 1.8 in cerebellar Purkinje cells: demyelinated axons and human multiple sclerosis
In mutant taiep (tremor, ataxia, immobility episodes, epilepsy, and paralysis) rats, myelin develops normally at first, but subsequently degenerates due to an abnormality of oligodendrocytes; after the loss of myelin, Na v 1.8 mRNA and protein levels were elevated in their cerebellar Purkinje cells (37) . In post-mortem analysis of human cerebellar Purkinje cells from multiple sclerosis patients, Na v 1.8 mRNA and protein levels were up-regulated, presumably being related to cerebellar ataxia seen in multiple sclerosis patients (37, 48) .
Na v aggregation at node of Ranvier: prerequisite for repairing remyelination of demyelinated axons in human multiple sclerosis
In addition to multiple sclerosis, demyelination can be induced in various diseases (e.g., viral infection and spinal cord injury) (13, 32, 33, 44) . Autopsy studies in humans and animals have increasingly pointed out that demyelination is necessary, but not sufficient per se for development of permanent deficits in multiple sclerosis; substantial demyelination can be observed in apparently normal individuals with no neurological deficits during their life (45, 98, 99) . In Theiler's murine encephalomyelitis virus model of demyelination, RiveraQuiñones et al. (99) observed that neurological functions were maintained in major histocompatibility complex class I-induced demyelination mice, compared to class II-induced demyelination mice, despite the similar extent and distribution of demyelinated lesions between these two mouse groups; the preservation of physiological functions in class I mice was likely due to the increased densities of sodium channels and the relative preservation of axons, compared to class II mice.
Demyelination predisposes axons to subsequent secondary injury (45) , whereas remyelination protects axons against secondary degeneration (35) . Demyelinated axons could be repaired by remyelination in humans (30) and rodents (33, 34) . In rodent models of demyelination, the regenerative process of remyelination could be effectively achieved (33, 34) . As the disease state of multiple sclerosis progresses, however, the remyelination process becomes insufficient, at least in part, due to the ongoing axon loss or axon denudation with the resultant disruption of axon-glia interactions, precipitating the reduced capacity of axon myelination (13, 31, 32) . New myelin sheaths are not produced by oligodendrocytes that survive demyelination, but are elaborated by oligodendrocyte precursor cells that proliferate, migrate, and differentiate into mature myelin sheath-forming oligodendrocytes (32) . In developing rat optic neurons, proliferation of oligodendrocyte precursor cells was promoted by neuronal electrical activity of adjacent axons (8, 9) ; conversely, blockade of the electrical activity by TTX injection decreased proliferation of oligodendrocyte precursor cells (8 (46, 47) . Na + currents via Na v 1.6 are larger than the Na + currents via Na v 1.2, raising the possibility that coexpression of Na + -Ca 2+ exchanger and Na v 1.6 (rather than Na v 1.2) may precipitate injury in demyelinated axons (44) . In spinal cord axons from multiple sclerosis model mice with experimental autoimmune encephalomyelitis, Craner et al. (50) tested the cellular distribution of β-amyloid precursor protein, a hallmark of axon injury (35, 100, 101) . Double-label immunocytochemistry showed that 92% of β-amyloid precursor proteinpositive axons expressed Na v 1.6, or coexpressed Na v 1.6 and Na v 1.2, whereas Na v 1.2 alone was expressed in only 1.8% of β-amyloid precursor protein-positive cells. In addition, 74% of β-amyloid precursor protein-positive axons coexpressed Na v 1.6 and Na + -Ca 2+ exchanger, whereas only 4% of β-amyloid precursor proteinnegative axons showed coexpression of Na v 1.6 and Na + -Ca 2+ exchanger (44, 50, 51) . Thus, Na v 1.6 and Na
exchanger were coexpressed within β-amyloid precursor protein-positive injured axons in the mouse model of multiple sclerosis. In human patients with multiple sclerosis, Craner et al. (51) examined cellular expression patterns of Na v 1.2 and Na v 1.6 by using post-mortem spinal cord and optic nerve tissues. In control white matter obtained from patients without neurological disease, myelin basic protein was enriched, and Na v 1.6 (but not Na v 1.2) was clustered at nodes of Ranvier. In active lesions from patients with multiple sclerosis, axons showed injured myelin, with diffuse distribution of Na v 1.6 and Na v 1.2 along the extensive myelin-lacking regions. In these active lesions, Na v 1.6 (but not Na v 1.2) and Na (46, 47) . Little is known about the molecular basis underlying noninactivating Na + currents. Because the sodium channel α-subunit harbors the cytoplasmic domain involved in inactivation of sodium channel opening (38) , persistent noninactivation of sodium channel opening can result from damage to the sodium channel α-subunit. Iwata et al. (102) examined whether traumatic axonal injury could affect structural integrity of sodium channels by using antibody that recognized all isoforms of sodium channel α-subunits. In cultured rat neocortical neurons, stretch injury increased cytoplasmic concentration of Ca 2+ for at least 60 min and caused a rapid (5 min ≤) proteolytic cleavage of sodium channel α-subunit at the cytoplasmic loop between domain III and IV, a domain involved in the inactivation of sodium channel opening. Pre-injury treatment of the axons with TTX completely abolished both posttraumatic increase in cytoplasmic Ca 2+ concentration and proteolysis of sodium channel α-subunit. In addition, pre-injury or post-injury inhibition of protease activity attenuated long-term increase in cytoplasmic Ca 2+ concentration and degradation of sodium channel α-subunit. These observations suggest that stretch injury caused opening of sodium channels followed by Ca 2+ overload, resulting in proteolytic cleavage of the inactivation domain of α-subunit; consequently, the persistent failure of inactivation of sodium channel causes sustained Na + influx, feeding forward longlasting Ca 2+ overload.
Expression of Na v 1.2 in demyelinated axon of multiple sclerosis: possible compensation In human patients with multiple sclerosis, Na v 1.2 and Na + -Ca 2+ exchanger were coexpressed diffusely along demyelinated, but noninjured (β-amyloid precursor protein-negative) axons (44, 50) . The situation seems to be similar to the widespread redistribution of Na v 1.2 along the mature stage of nonmyelinated axons or premyelinated stage of myelinated axons, which normally initiate and propagate action potentials. Therefore, Waxman and his colleagues (44) proposed that derepressed expression of Na v 1.2 along demyelinated axons might be adaptive, supporting action potentials for remission of clinical deficits in multiple sclerosis. Besides Na v 1.2, Na v 1.6, Na + -Ca 2+ exchanger, and Ca 2+ overload, the molecular mechanisms of multiple sclerosis have been increasingly unveiled in terms of the inflammation, inflammatory plaque, demyelination / remyelination, relapse / remission, progressive neurodegeneration, and multiple options for potential therapeutic strategies; these topics are summarized in a recent review article (103) .
Conclusions
Heterogeneous patterns of action potentials are decoded into distinct ionic and metabolic signalings and coordinate functions of central and peripheral nervous system as a whole, depending on the established neuronal circuits in adulthood. The detailed map for neuronal circuits, however, is not encoded in genes. Instead, sodium channels sculpt and maintain per se structures of neuronal circuits consistently from the early stage of development through adulthood; it is accomplished by electrical activity-dependent, not-fully defined mechanisms, including the reciprocal interactions between neurons and glial cells at the synapses and axons via neurotransmitters, ATP, adenosine, and growth factors, as well as cytokines. In addition, remyelination of demyelinated axons in neurodegenerative diseases (e.g., multiple sclerosis), experience-driven cognitive functions (e.g., piano practicing), and epigenetic homeostasis-based selection of neuron-specific neurotransmitter phenotype require sodium channelinduced functional integrity and structural stability of neuronal circuits. Up-and down-regulations of multiple isoforms of sodium channel molecules occur in response to various noxious insults, which may be the basis for adaptive and maladaptive neuronal remodelings. Last, but not least, pain research has developed into the new era, cultivating drug treatment focused on specific isoforms of sodium channel molecules. Sodium channel research has unveiled new horizons toward the comprehensive resolution of many challenging issues in the basic and clinical sciences.
